The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Top Cited Papers
- 4 June 2014
- journal article
- review article
- Published by Springer Nature in Nature
- Vol. 510 (7503) , 84-91
Abstract
Non-alcoholic fatty liver disease and its downstream sequelae, hepatic insulin resistance and type 2 diabetes, are rapidly growing epidemics, which lead to increased morbidity and mortality rates, and soaring health-care costs. Developing interventions requires a comprehensive understanding of the mechanisms by which excess hepatic lipid develops and causes hepatic insulin resistance and type 2 diabetes. Proposed mechanisms implicate various lipid species, inflammatory signalling and other cellular modifications. Studies in mice and humans have elucidated a key role for hepatic diacylglycerol activation of protein kinase Cε in triggering hepatic insulin resistance. Therapeutic approaches based on this mechanism could alleviate the related epidemics of non-alcoholic fatty liver disease and type 2 diabetes.Keywords
This publication has 122 references indexed in Scilit:
- Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in ratsHepatology, 2012
- Regulation of the structure and activity of pyruvate carboxylase by acetyl CoAArchives of Biochemistry and Biophysics, 2012
- Localisation and composition of skeletal muscle diacylglycerol predicts insulin resistance in humansDiabetologia, 2012
- Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistanceHepatology, 2011
- Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerolDiabetologia, 2011
- Dissociation betweenAPOC3variants, hepatic triglyceride content and insulin resistanceHepatology, 2010
- Lipid oversupply, selective insulin resistance, and lipotoxicity: Molecular mechanismsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical ImplicationsHepatology, 2010
- Selective versus Total Insulin Resistance: A Pathogenic ParadoxCell Metabolism, 2008
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005